Published in Transl Stroke Res on March 01, 2011
Epigenetic impact of curcumin on stroke prevention. Metab Brain Dis (2014) 0.89
Harnessing the master transcriptional repressor REST to reciprocally regulate neurogenesis. Neurogenesis (Austin) (2015) 0.75
Genome-wide mapping of in vivo protein-DNA interactions. Science (2007) 64.92
Translating the histone code. Science (2001) 56.77
Chromatin modifications and their function. Cell (2007) 55.98
Long noncoding RNA as modular scaffold of histone modification complexes. Science (2010) 15.23
Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains. PLoS Genet (2008) 11.17
Multivalent engagement of chromatin modifications by linked binding modules. Nat Rev Mol Cell Biol (2007) 8.14
Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell (2008) 7.79
Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. Genes Dev (2007) 6.71
The science of stroke: mechanisms in search of treatments. Neuron (2010) 6.14
A genetic screen for candidate tumor suppressors identifies REST. Cell (2005) 5.61
Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase. Mol Cell (2007) 5.49
CoREST: a functional corepressor required for regulation of neural-specific gene expression. Proc Natl Acad Sci U S A (1999) 4.59
p53 is regulated by the lysine demethylase LSD1. Nature (2007) 4.53
The logic of chromatin architecture and remodelling at promoters. Nature (2009) 3.63
Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells. Proc Natl Acad Sci U S A (2004) 3.60
The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation. Nature (2007) 3.55
Mediator links epigenetic silencing of neuronal gene expression with x-linked mental retardation. Mol Cell (2008) 3.53
Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9. Nat Chem Biol (2005) 3.49
2-Deoxy-D-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure. Nat Neurosci (2006) 3.36
Comparative genomics modeling of the NRSF/REST repressor network: from single conserved sites to genome-wide repertoire. Genome Res (2006) 3.23
Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications. Chem Biol (2006) 3.15
Chromatin remodelling factor Mll1 is essential for neurogenesis from postnatal neural stem cells. Nature (2009) 2.87
SCFbeta-TRCP controls oncogenic transformation and neural differentiation through REST degradation. Nature (2008) 2.84
A homozygous mutation in human PRICKLE1 causes an autosomal-recessive progressive myoclonus epilepsy-ataxia syndrome. Am J Hum Genet (2008) 2.58
Comparative sequence analysis reveals an intricate network among REST, CREB and miRNA in mediating neuronal gene expression. Genome Biol (2006) 2.49
Control of chromosome stability by the beta-TrCP-REST-Mad2 axis. Nature (2008) 2.46
A new binding motif for the transcriptional repressor REST uncovers large gene networks devoted to neuronal functions. J Neurosci (2007) 2.45
Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression. PLoS Genet (2010) 2.39
Moving AHEAD with an international human epigenome project. Nature (2008) 2.38
Loss-of-function mutations in euchromatin histone methyl transferase 1 (EHMT1) cause the 9q34 subtelomeric deletion syndrome. Am J Hum Genet (2006) 2.31
Forebrain neurogenesis after focal Ischemic and traumatic brain injury. Neurobiol Dis (2009) 2.11
Ischemic insults derepress the gene silencer REST in neurons destined to die. J Neurosci (2003) 2.08
H2A.Z: view from the top. Structure (2008) 2.07
BRIT1/MCPH1 links chromatin remodelling to DNA damage response. Nat Cell Biol (2009) 2.06
trans-2-Phenylcyclopropylamine is a mechanism-based inactivator of the histone demethylase LSD1. Biochemistry (2007) 1.97
CDYL bridges REST and histone methyltransferases for gene repression and suppression of cellular transformation. Mol Cell (2008) 1.94
Epigenetic control of neural precursor cell fate during development. Nat Rev Neurosci (2010) 1.93
Discovery of a 2,4-diamino-7-aminoalkoxyquinazoline as a potent and selective inhibitor of histone lysine methyltransferase G9a. J Med Chem (2009) 1.92
The neuronal repressor REST/NRSF is an essential regulator in medulloblastoma cells. Nat Med (2000) 1.92
Novel oligoamine analogues inhibit lysine-specific demethylase 1 and induce reexpression of epigenetically silenced genes. Clin Cancer Res (2009) 1.87
Abnormal expression of REST/NRSF and Myc in neural stem/progenitor cells causes cerebellar tumors by blocking neuronal differentiation. Mol Cell Biol (2006) 1.83
Hypoxic stress induces dimethylated histone H3 lysine 9 through histone methyltransferase G9a in mammalian cells. Cancer Res (2006) 1.78
Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype. J Med Genet (2009) 1.74
Protein lysine methyltransferase G9a inhibitors: design, synthesis, and structure activity relationships of 2,4-diamino-7-aminoalkoxy-quinazolines. J Med Chem (2010) 1.73
The polycomb group gene Bmi1 regulates antioxidant defenses in neurons by repressing p53 pro-oxidant activity. J Neurosci (2009) 1.64
Epigenetic regulation of the INK4b-ARF-INK4a locus: in sickness and in health. Epigenetics (2010) 1.63
Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming. Trends Pharmacol Sci (2009) 1.59
Inflammatory cytokines in acute ischemic stroke. Curr Pharm Des (2008) 1.54
Epigenetic principles and mechanisms underlying nervous system functions in health and disease. Prog Neurobiol (2008) 1.53
The HDAC inhibitor, sodium butyrate, stimulates neurogenesis in the ischemic brain. J Neurochem (2009) 1.53
Stem cells for ischemic brain injury: a critical review. J Comp Neurol (2009) 1.53
REST in good times and bad: roles in tumor suppressor and oncogenic activities. Cell Cycle (2006) 1.51
Histone demethylase LSD1 regulates neural stem cell proliferation. Mol Cell Biol (2010) 1.47
Genome-wide impact of the BRG1 SWI/SNF chromatin remodeler on the transforming growth factor beta transcriptional program. J Biol Chem (2007) 1.43
Targeting histone deacetylases as a multifaceted approach to treat the diverse outcomes of stroke. Stroke (2009) 1.42
Transcriptional regulation: cancer, neurons and the REST. Curr Biol (2005) 1.41
Many human medulloblastoma tumors overexpress repressor element-1 silencing transcription (REST)/neuron-restrictive silencer factor, which can be functionally countered by REST-VP16. Mol Cancer Ther (2005) 1.37
Structurally designed trans-2-phenylcyclopropylamine derivatives potently inhibit histone demethylase LSD1/KDM1 . Biochemistry (2010) 1.36
REST and CoREST modulate neuronal subtype specification, maturation and maintenance. PLoS One (2009) 1.34
Ischemic insults promote epigenetic reprogramming of mu opioid receptor expression in hippocampal neurons. Proc Natl Acad Sci U S A (2007) 1.34
Trithorax requires Hsp90 for maintenance of active chromatin at sites of gene expression. Proc Natl Acad Sci U S A (2009) 1.31
Polycomb group proteins as epigenetic mediators of neuroprotection in ischemic tolerance. Sci Signal (2010) 1.31
Comparative analysis of small molecules and histone substrate analogues as LSD1 lysine demethylase inhibitors. J Am Chem Soc (2010) 1.29
Putting the 'HAT' back on survival signalling: the promises and challenges of HDAC inhibition in the treatment of neurological conditions. Expert Opin Investig Drugs (2009) 1.28
Differentiation of neural stem cells into oligodendrocytes: involvement of the polycomb group protein Ezh2. Stem Cells (2008) 1.26
Epigenetic regulation: methylation of histone and non-histone proteins. Sci China C Life Sci (2009) 1.24
Hypoxic repression of endothelial nitric-oxide synthase transcription is coupled with eviction of promoter histones. J Biol Chem (2009) 1.20
Differential deployment of REST and CoREST promotes glial subtype specification and oligodendrocyte lineage maturation. PLoS One (2009) 1.20
Roles of Brahma and Brahma/SWI2-related gene 1 in hypoxic induction of the erythropoietin gene. J Biol Chem (2004) 1.19
The JARID2-PRC2 duality. Genes Dev (2010) 1.18
Regulation of neural macroRNAs by the transcriptional repressor REST. RNA (2008) 1.18
Regulation of non-coding RNA networks in the nervous system--what's the REST of the story? Neurosci Lett (2009) 1.16
Dietary omega-3 polyunsaturated fatty acids suppress expression of EZH2 in breast cancer cells. Carcinogenesis (2009) 1.14
Activity-dependent neuroprotective protein constitutes a novel element in the SWI/SNF chromatin remodeling complex. J Biol Chem (2007) 1.12
Genome analysis identifies the p15ink4b tumor suppressor as a direct target of the ZNF217/CoREST complex. Mol Cell Biol (2008) 1.12
Neural stem cells in the developing and adult brains. J Cell Physiol (2009) 1.11
TGF-beta 1 polymorphisms and risk of myocardial infarction and stroke: the Rotterdam Study. Stroke (2006) 1.11
Renal ischemia-reperfusion injury upregulates histone-modifying enzyme systems and alters histone expression at proinflammatory/profibrotic genes. Am J Physiol Renal Physiol (2009) 1.10
Valproic acid promotes neuronal differentiation by induction of proneural factors in association with H4 acetylation. Neuropharmacology (2008) 1.06
Analysis of the binding of mixed lineage leukemia 1 (MLL1) and histone 3 peptides to WD repeat domain 5 (WDR5) for the design of inhibitors of the MLL1-WDR5 interaction. J Med Chem (2010) 0.97
Drosophila genome-wide RNAi screen identifies multiple regulators of HIF-dependent transcription in hypoxia. PLoS Genet (2010) 0.96
Overexpression of human histone methylase MLL1 upon exposure to a food contaminant mycotoxin, deoxynivalenol. FEBS J (2009) 0.96
Docosahexaenoic acid neurolipidomics. Prostaglandins Other Lipid Mediat (2009) 0.95
Polyamine analogues targeting epigenetic gene regulation. Essays Biochem (2009) 0.95
Mechanistic insight into DNA damage and repair in ischemic stroke: exploiting the base excision repair pathway as a model of neuroprotection. Antioxid Redox Signal (2010) 0.91
Bmi-1 regulates self-renewal, proliferation and senescence of human fetal neural stem cells in vitro. Neurosci Lett (2010) 0.90
SAR and QSAR study on 2-aminothiazole derivatives, modulators of transcriptional repression in Huntington's disease. Bioorg Med Chem (2008) 0.89
Molecular genetic analysis of the REST/NRSF gene in nervous system tumors. Acta Neuropathol (2006) 0.89
Loss of huntingtin function complemented by small molecules acting as repressor element 1/neuron restrictive silencer element silencer modulators. J Biol Chem (2007) 0.87
Small molecules that promote neurogenesis in vitro. Recent Pat CNS Drug Discov (2008) 0.84
Distribution of lysine-specific demethylase 1 in the brain of rat and its response in transient global cerebral ischemia. Neurosci Res (2010) 0.82
Fate and manipulations of endogenous neural stem cells following brain ischemia. Expert Opin Biol Ther (2009) 0.82
Turning REST/NRSF dysfunction in Huntington's disease into a pharmaceutical target. Curr Pharm Des (2009) 0.81
Neuroprotective effect of the peptides ADNF-9 and NAP on hypoxic-ischemic brain injury in neonatal rats. Brain Res (2006) 0.81
Eradicating the mediators of neuronal death with a fine-tooth comb. Sci Signal (2010) 0.80
Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science (2010) 12.15
Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest (2007) 8.71
Specific expression of long noncoding RNAs in the mouse brain. Proc Natl Acad Sci U S A (2008) 7.19
Long non-coding RNAs in nervous system function and disease. Brain Res (2010) 2.53
RNA regulation of epigenetic processes. Bioessays (2009) 2.53
Emerging roles of non-coding RNAs in brain evolution, development, plasticity and disease. Nat Rev Neurosci (2012) 2.52
Long noncoding RNAs in neuronal-glial fate specification and oligodendrocyte lineage maturation. BMC Neurosci (2010) 2.34
Transgenic overexpression of BMP4 increases astroglial and decreases oligodendroglial lineage commitment. Dev Biol (2003) 1.75
RNA editing, DNA recoding and the evolution of human cognition. Trends Neurosci (2008) 1.70
The CSF-1 receptor ligands IL-34 and CSF-1 exhibit distinct developmental brain expression patterns and regulate neural progenitor cell maintenance and maturation. Dev Biol (2012) 1.50
Combinatorial profiles of oligodendrocyte-selective classes of transcriptional regulators differentially modulate myelin basic protein gene expression. J Neurosci (2005) 1.47
Differential modulation of BMP signaling promotes the elaboration of cerebral cortical GABAergic neurons or oligodendrocytes from a common sonic hedgehog-responsive ventral forebrain progenitor species. Proc Natl Acad Sci U S A (2002) 1.37
REST and CoREST modulate neuronal subtype specification, maturation and maintenance. PLoS One (2009) 1.34
REST and CoREST are transcriptional and epigenetic regulators of seminal neural fate decisions. Cell Cycle (2010) 1.24
Noncoding RNAs in Long-Term Memory Formation. Neuroscientist (2008) 1.22
Differential deployment of REST and CoREST promotes glial subtype specification and oligodendrocyte lineage maturation. PLoS One (2009) 1.20
Impairment of developmental stem cell-mediated striatal neurogenesis and pluripotency genes in a knock-in model of Huntington's disease. Proc Natl Acad Sci U S A (2009) 1.17
Regulation of non-coding RNA networks in the nervous system--what's the REST of the story? Neurosci Lett (2009) 1.16
Profiling RE1/REST-mediated histone modifications in the human genome. Genome Biol (2009) 1.16
Corepressor for element-1-silencing transcription factor preferentially mediates gene networks underlying neural stem cell fate decisions. Proc Natl Acad Sci U S A (2010) 1.12
Epigenetic mechanisms underlying human epileptic disorders and the process of epileptogenesis. Neurobiol Dis (2010) 1.11
Emerging role of epigenetics in stroke: part 1: DNA methylation and chromatin modifications. Arch Neurol (2010) 1.09
Long non-coding RNAs: novel targets for nervous system disease diagnosis and therapy. Neurotherapeutics (2013) 1.02
The emerging role of epigenetics in stroke: II. RNA regulatory circuitry. Arch Neurol (2010) 0.98
De novo neurogenesis and acute stroke: are exogenous stem cells really necessary? Neurosurgery (2004) 0.97
Genetic and epigenetic underpinnings of sex differences in the brain and in neurological and psychiatric disease susceptibility. Prog Brain Res (2010) 0.97
Non-coding RNA networks underlying cognitive disorders across the lifespan. Trends Mol Med (2011) 0.96
Receptor-type protein-tyrosine phosphatase ζ is a functional receptor for interleukin-34. J Biol Chem (2013) 0.91
Advances in epigenetics and epigenomics for neurodegenerative diseases. Curr Neurol Neurosci Rep (2011) 0.89
Towards a 'systems'-level understanding of the nervous system and its disorders. Trends Neurosci (2013) 0.85
Selective roles of normal and mutant huntingtin in neural induction and early neurogenesis. PLoS One (2013) 0.85
The emerging role of epigenetics in stroke: III. Neural stem cell biology and regenerative medicine. Arch Neurol (2011) 0.85
Epigenetic mechanisms governing the process of neurodegeneration. Mol Aspects Med (2012) 0.83
Impact of nuclear organization and dynamics on epigenetic regulation in the central nervous system: implications for neurological disease states. Ann N Y Acad Sci (2010) 0.82
Understanding neurological disease mechanisms in the era of epigenetics. JAMA Neurol (2013) 0.81
Epigenetics of sleep and chronobiology. Curr Neurol Neurosci Rep (2014) 0.80
Epigenetic mechanisms underlying the pathogenesis of neurogenetic diseases. Neurotherapeutics (2014) 0.80
Functions of huntingtin in germ layer specification and organogenesis. PLoS One (2013) 0.80
Development and neurodegeneration: turning HD pathogenesis on its head. Neurology (2012) 0.79
Developing epigenetic diagnostics and therapeutics for brain disorders. Trends Mol Med (2013) 0.78
Epigenetics, nervous system tumors, and cancer stem cells. Cancers (Basel) (2011) 0.77
Emerging themes in epigenetics: implications for understanding and treating nervous system disorders. Epigenomics (2010) 0.77
Alu transcription: a rheostat for stem cell aging? Cell Cycle (2011) 0.75
Introduction: epigenetics and neuropsychiatric diseases. Neurobiol Dis (2010) 0.75